Predicted LncRNA

DataTables

LncRNA Compound Cancer P-value Effect
ENSG00000257443.1 ABT-263 (navitoclax) Pancreatic adenocarcinoma 0.019813402 Resistant
ENSG00000257443.1 ABT-263 (navitoclax) Liver hepatocellular carcinoma 0.036715133 Sensitive